Methods for Screening the Potential Antitumor Activity of Platinum Compounds in Combinatorial Libraries

Cisplatin: Chemistry and Biochemistry of a Leading Anticancer Drug

Volumn , Issue , 2006, Pages 523-536

  Sandman, Karen E ^a   Lippard, Stephen J ^a  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

Cancer treatment; Cisplatin; Combinatorial libraries; Platinum compounds; Potential antitumor activity; Screening methods

Indexed keywords

BIOCHIPS; CHEMOTHERAPY; DIAGNOSIS; DISEASES; DRUG PRODUCTS; LIBRARIES; ONCOLOGY;

ANTI-TUMOR ACTIVITIES; CIS-PLATIN; COMBINATORIAL APPROACH; COMBINATORIAL CHEMISTRY; COMBINATORIAL LIBRARY; HIGH-THROUGHPUT TECHNOLOGIES; SCREENING METHODS; SYNTHETIC METHODOLOGY;

PLATINUM COMPOUNDS;

EID: 84949221595     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9783906390420.ch21     Document Type: Chapter

References (29)

1. T.W. Hambley, Coord. Chem. Rev. 1997, 166, 181.
2. M.J. Bloemink, J. Reedijk, Met. Ions Biol. Syst. 1996, 32, 641.
3. N. Farrell, Y. Qu, U. Bierbach, M. Valsecchi, E. Menta, in 'Cisplatin -Chemistry and Biochemistry of a Leading Anticancer Drug', Ed.B. Lippert, Verlag Helvetica Chimica Acta, Zürich, 1999, p. 479
4. L. Kelland, in 'Cisplatin -Chemistry and Biochemistry of a Leading Anticancer Drug', Ed.B. Lippert, Verlag Helvetica Chimica Acta, Zürich, 1999, p. 497
5. M.A. Gallop, R.W. Barrett, W.J. Dower, S.P.A. Fodor, E.M. Gordon, J. Med. Chem. 1994, 37, 1233.
6. E.M. Gordon, M.A. Gallop, D.V. Patel, Acc. Chem. Res. 1996, 29, 144.
7. K.S. Lam, Anti-Cancer Drug Design 1997, 12, 145.
8. K.E. Sandman, P. Fuhrmann, S.J. Lippard, J. Biol. Inorg. Chem. 1998, 3, 74.
9. E.M. Gordon, R.W. Barrett, W.J. Dower, S.P.A. Fodor, M.A. Gallop, J. Med. Chem. 1994, 37, 1385.
10. J.A. Ellman, Acc. Chem. Res. 1996, 29, 132.
11. F. Balkenhohl, C.v.d. Bussche-Hunnefeld, A. Lansky, C. Zechel, Angew. Chem. Int. Ed. Engl. 1996, 35, 2288.
12. M.B. Francis, T.F. Jamison, E.N. Jacobsen, Curr. Opin. Chem. Biol. 1998, 2, 422.
13. H.X. Lin, Z.L. Li, G.L. Dai, Q.S. Bi, R.Q. Yu, Sci. China Ser. B 1993, 36, 1216.
14. S.J. Lippard, Acc. Chem. Res. 1978, 11, 211.
15. V. Murray, H. Motyka, P.R. England, G. Wickham, H.H. Lee, W.A. Denny, W.D. McFadyen, Biochemistry 1992, 31, 11812.
16. D.B. Zamble, S.J. Lippard, in 'Cisplatin -Chemistry and Biochemistry of a Leading Anticancer Drug', Ed.B. Lippert, Verlag Helvetica Chimica Acta, Zürich, 1999, p. 73.
17. C.J. Ziegler, K.E. Sandman, C.H. Liang, S.J. Lippard, submitted for publication.
18. J.M. Brown, Oncol. Res. 1997, 9, 213.
19. R.P. Perez, A.K. Godwin, L.M. Handel, T.C. Hamilton, Eur.J. Cancer 1993, 29A, 395.
20. E. Borenfreund, H. Babich, N. Martin-Alguacil, In vitro Cell. Dev. Biol. 1990, 26, 1030.
21. S.P. Fricker, R.G. Buckley, Anticancer Res. 1996, 16, 3755.
22. D. Fink, S. Nebel, P.S. Norris, S. Aebi, H.K. Kim, M. Haas, S.B. Howell, Brit.J. Cancer 1998, 77, 703.
23. D.A. Anthoney, A.J. McIlwrath, W.M. Gallagher, A.R.M. Edlin, R. Brown, Cancer Res. 1996, 56, 1374.
24. K.E. Sandman, G. Zlokarnik, S.J. Lippard, submitted for publication.
25. G. Zlokarnik, P.A. Negulescu, T.E. Knapp, L. Mere, N. Burres, L. Feng, M. Whitney, K. Roemer, R.Y. Tsien, Science 1998, 279, 84.
26. G. Schwartsmann, P. Workman, Eur.J. Cancer 1993, 29A, 3.
27. T. Sprub, G. Bernhardt, E. Schickaneder, H. Schönenberger, J. Cancer Res. Clin. Oncol. 1991, 117, 435.
28. L.R. Kelland, M. Jones, G. Abel, M. Valenti, J. Gwynne, K.R. Harrap, Cancer Chemo. Pharm. 1992, 30, 43.
29. V.B. Ivanov, M.J. Bloemink, P.A. Cheltsov, E.I. Bystrova, T.N. Fedotova, J. Reedijk, BioMetals 1996, 9, 249.